CLYM Climb Bio, Inc. Year-over-year net earnings per share growth for the last 12 months
Climb Bio Inc (CLYM) relies on a diversified portfolio of drugs to combat immune pathologies, and its laboratories are operating seamlessly. However, the lack of sales and dependence on capital make the risk of early-stage test failure critical, as confirmed by the quarterly EPS trend on the GURU.Markets portal, where the latest parameter stands at 3.90, allowing for an objective assessment of profit dynamics.
Analytical breakdowns and data insights for company Climb Bio, Inc (CLYM)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
- earnings and market multiples details:
CLYM - Company Net Income|Future Profit Climb Bio Inc|CLYM - Company Value to Net Income|Forward P/E Multiple Climb Bio, Inc.|CLYM - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Climb Bio Inc|CLYM - Operating income before deduction of amortization|Earnings per share for the last twelve months Climb Bio|CLYM - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months climbbio.com|CLYM - Earnings per share increase in current year|Earnings growth forecast for next year Climb Bio Inc
Fundamental valuation:Climb Bio - CLYM
Fundamental analysis of earnings per share allows for an assessment of business capitalization efficiency. This metric measures net value growth, accounting for fiscal adjustments and government support. By analyzing the quarterly EPS chart, an investor tracks the operational yield dynamics between reports. For Climb Bio Inc (CLYM), this indicator reflects financial stability during the development of orphan disease therapies. Growth in this metric confirms the successful scaling of innovations within the immunology segment.
Competitors of Climb Bio Inc (CLYM)
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Corp - Quarterly EPS earnings growth|Celldex Corp (CLDX) - Year-over-year net earnings per share growth for the last 12 months|Aurinia Pharmaceuticals (AUPH) - Year-over-year earnings per share growth for the last twelve months|BCRX (biocryst.com) - Year-over-year earnings per share growth for the last twelve months|VERA (Vera Therapeutics) - Quarterly EPS earnings growth|Dianthus Therapeutics Inc (DNTH) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Pharvaris Corp (PHVS)|Year-over-year net earnings per share growth for the last 12 months AbCellera Bio ABCL|Quarterly EPS earnings growth TRML (Tourmaline Bio, Inc.)|precigen.com - Year-over-year earnings per share growth for the last twelve months|PHAR: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months NKTR (Nektar Therapeutics Inc)|UPB: Quarterly EPS earnings growth|ZBIO (Zenas Corp) - Year-over-year earnings per share growth for the last twelve months|IMNM (Immunome, Inc.) - Quarterly EPS earnings growth|gossamerbio.com (GOSS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months KalVista Pharmaceuticals, Inc. (KALV)|SEPN - Earnings per share growth in annualized terms for the last twelve months|Pieris Pharmaceuticals Inc - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SVRA|Rigel Pharmaceuticals - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months anaptysbio.com ANAB|Astria Therapeutics, Inc. (ATXS) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months ENGN|RAPT (RAPT Therapeutics) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Aerovate (JBIO)|Quarterly EPS earnings growth ACRS|Year-over-year net earnings per share growth for the last 12 months kyvernatx.com KYTX|Year-over-year earnings per share growth for the last twelve months Tiziana Life Sciences Ltd TLSA|Cabaletta Bio Inc. - Year-over-year earnings per share growth for the last twelve months|VTYX: Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months Theratechnologies, Inc|Avalo Therapeutics, Inc (AVTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months eledon.com|Year-over-year earnings per share growth for the last twelve months Agenus Inc.|zurabio.com - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth ATYR|ADAG (adagene.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth IMA (Ikena Oncology)|Quarterly EPS earnings growth Shattuck Labs Inc STTK|EQ - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months CNTB (Connect Biopharma)|immunic-therapeutics.com (IMUX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Atara Bio|IFRX (InflaRx NV) - Quarterly EPS earnings growth|Quarterly EPS earnings growth x4pharma.com|Year-over-year net earnings per share growth for the last 12 months ACET (Adicet Bio)|CELU (celularity.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth INMB (INmune Bio Corp)|Year-over-year net earnings per share change for the last twelve months Barinthus Biotherapeutics Corp (BRNS)|KZR - Year-over-year earnings per share growth for the last twelve months|sabbiotherapeutics.com (SABS) - Year-over-year net earnings per share growth for the last 12 months|Akari Therapeutics Plc (AKTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Enlivex Therapeutics Ltd.|Year-over-year net earnings per share growth for the last 12 months QTTB|Quarterly EPS earnings growth GeoVax Corp|Year-over-year earnings per share growth for the last twelve months Edesa Biotech, Inc. (EDSA)|ibioinc.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth CARM (Carisma Therapeutics Inc.)|XTL Biopharmaceuticals Ltd (XTLB) - Earnings per share growth in annualized terms for the last twelve months|Bolt Bio - Quarterly EPS earnings growth|HCW Biologics Inc. (HCWB) - Year-over-year net earnings per share growth for the last 12 months|aptevotherapeutics.com (APVO) - Year-over-year earnings per share growth for the last twelve months|AIM (aimimmuno.com) - Year-over-year earnings per share growth for the last twelve months|ADTX (Aditxt Inc.) - Quarterly EPS earnings growth|GRI Bio Inc (GRI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months XORTX (XRTX)|Year-over-year net earnings per share growth for the last 12 months Vyome Therapeutics HIND|Quarterly EPS earnings growth REVB (Revelation Biosciences)|indaptusrx.com - Year-over-year earnings per share growth for the last twelve months|SCNI: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months CALI (CalciMedica, Inc.)|AFMD: Quarterly EPS earnings growth|ALLK (Allakos) - Year-over-year earnings per share growth for the last twelve months|HOOK (HOOKIPA Pharma, Inc.) - Quarterly EPS earnings growth|IGM Bio (IGMS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months iTeos Therapeutics, Inc. (ITOS)|OCEA - Earnings per share growth in annualized terms for the last twelve months|TC BioPharm (Holdings) PLC - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months THRD
